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Colorectal cancer (CRC) is the most common cancer
and the third leading cause of cancer death in Taiwan.
It was estimated that more than 10,000 patients were
diagnosed with CRC and more than 4,100 patients
died of this disease in 2006 in Taiwan [1]. This disease
has one of the highest rates of increased incidence in
Taiwan, and has gradually approached the incidence
in Western countries. Even with recent advances in
diagnostic modalities, anti-cancer drugs, and surgical
techniques, the outcome of advanced CRC remains
poor, and the 5-year survival rate has not improved
significantly [2–4]. Despite complete surgical resection,
about half of the patients die due to recurrence or
metastasis of this disease [4–6] and recurrence or me-
tastasis occurs within 3 years after resection in 70–80%
of patients [7,8]. It has been reported that 93–95% of
patients experience relapse within 5 years of primary
tumor resection [9], and very few patients remain
disease-free survival for more than 10 years. Here we
report a very rare case of postoperative recurrence
with an initial presentation of hematuria, 13 years
after primary colonic cancer resection.
CASE PRESENTATION
A 72-year-old male patient underwent surgical resec-
tion of sigmoid colonic cancer [International Union
Against Cancer (UICC) stage II] at another regional
hospital in 1994. He was free of clinical recurrence or
metastasis during a 5-year follow-up program at 
the same hospital. However, since June 2007, this
patient has complained of hematuria and he visited a
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We report a rare case of postoperative colon cancer recurrence who presented with hematuria 13
years after resection of the primary colonic cancer. The patient was 72 years of age and under-
went surgical resection of sigmoid colon cancer at another regional hospital in 1994. Since June
2007, this patient has complained of hematuria and bloody stool. On physical examination, ten-
derness and a hard, indurated mass was palpable in the lower mid-abdomen. Abdominal com-
puted tomography showed a metastatic tumor at the lower midline peritoneum with invasion of
the adjacent abdominal wall. Her serum carcinoembryonic antigen level was elevated to
32 ng/dL. Histopathology revealed metastatic colonic adenocarcinoma in the jejunum and
abdominal wall.
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urological clinic, but no significant improvement was
obtained. Therefore, he was referred to the Division
of Urology at Kaohsiung Hospital for further man-
agement. The laboratory tests, including routine
urine analysis, revealed a red blood cell level of more
than 100 cells/high-power field. Cystoscopic exami-
nation revealed that the domed part of the bladder
was slightly hyperemic, but there were no other obvi-
ous gross lesions. At the same time, the patient also
complained of bloody stool, and colonoscopy
showed a benign colonic polyp and mixed hemor-
rhoids. Colonoscopic polypectomy revealed an ade-
nomatous polyp in this patient.
Three months after the patient’s first visit to our
hospital, he experienced lower abdominal pain and
distension, and visited our outpatient department
again. On physical examination, tenderness and a
hard, indurated mass was palpable in the lower mid-
abdomen. Laboratory tests revealed a decreased hemo-
globin level of 10.4 g/dL. His serum carcinoembryonic
antigen level was elevated to 32 ng/mL. Abdominal
computed tomography showed a metastatic tumor at
the lower midline peritoneum with invasion of the
adjacent abdominal wall (Figure 1A), and the recur-
rent tumor adhering to the urinary bladder (Figure
1B). Under the suspicion of recurrent colon cancer, an
exploratory laparotomy was performed. During the
operation, we found a tumor mass (5 × 4 cm in size)
that was adhered to the jejunum and the wall of the
bladder. Therefore, a segmental resection of the small
intestine and partial cystectomy was performed.
Histopathology demonstrated that the mucosa of
the jejunum was eroded, but there was no significant
pathologic change. Diffusely neoplastic glands infil-
trating the submucosa, muscularis propria, and serosa
of the jejunum were present. The neoplastic glands
were lined by tall columnar epithelial cells with pleo-
morphic hyperchromatic nuclei (Figure 2A). In addi-
tion to the presence of a desmoplastic reaction and
tumor cell necrosis (Figure 2A), vascular invasion
(Figure 2B), lymphatic invasion (Figure 2C), and per-
ineural invasion (Figure 2D) were observed. Immu-
nohistochemistry showed that the neoplastic cells were
positive for cytokeratin 20 (Figure 3A), which was
consistent with metastatic adenocarcinoma from the
colonic origin (Figure 3B). Thus, the diagnosis of recur-
rent sigmoid tumor invasion of the distal jejunum and
abdominal wall was made.
Postoperatively, the patient recovered well and
was discharged uneventfully. He received the che-
motherapy regimen of oxaliplatin/5-fluorouracil/
folinic acid (FOLFOX-4) to treat of his relapsed colonic
cancer.
DISCUSSION
According to the standard guidelines for postopera-
tive follow-up for CRC, published by the National
Comprehensive Cancer Network Clinical Practice
Guidelines in Oncology™ in 2008 [10], a 5-year follow-
up program should be undertaken postoperatively,
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Figure 1. (A) Metastatic tumor at the lower midline of the peritoneum and invasion of the adjacent abdominal wall (arrow). (B) The
recurrent tumor has adhered to the urinary bladder (arrow).
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and should include documentation of the patient’s
medical history, physical examination, measurement
of carcinoembryonic antigen, colonoscopic examina-
tion, and computed tomography every year, because of
the high risk of recurrence. It has been reported that
93–95% of patients with CRC experience relapse
within 5 years of primary tumor resection and the
incidence of postoperative recurrence or metastasis
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Figure 2. (A) Diffusely neoplastic glands infiltrating the submucosa and muscularis propria of the jejunum [hematoxylin and eosin
(H&E) stain; original magnification, 10×]. (B) Vascular invasion of adenocarcinoma cells (H&E stain, 40×). (C) Lymphatic invasion
of adenocarcinoma cells (H&E stain, 100×). (D) Perineural invasion of adenocarcinoma cells (H&E stain, 100×).
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Figure 3. (A) Neoplastic cells positive for cytokeratin 20 (original magunification, 40×); (B) Neoplastic cells positive for cytokeratin
20 (original magnification, 200×).
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of CRC after 10 years is extremely rare [9]. In another
study of patients with CRC who were followed-up
for a minimum of 10 years after curative resection,
the cumulative recurrence rate of CRC was 100% at 4
years and, for rectal cancer, the 5-, 7-, and 10-year
rates were 89%, 98%, and 100%, respectively [10].
Accordingly, postoperative relapse 13 years after
resection of the primary tumor is exceedingly rare
[11]. Therefore, tumor recurrence or metastasis may
be overlooked by physicians and patients. The current
patient in whom postoperative recurrent colonic can-
cer was diagnosed 13 years after resection as a result of
hematuria and lower abdominal pain, should remind
physicians and patients of the importance of appropri-
ate management of patients with history of cancer if
they show any clinical symptoms or signs.
Based on a MEDLINE literature search spanning
the period between January 1966 and December 2008,
very few cases of colon cancer relapse have been
reported in which the patient initially presented with
hematuria after the primary tumor resection. Hobdy
et al [12] reported a 75-year-old man with sigmoid can-
cer (UICC stage III, T3N1M0) who was found to have
transitional cell carcinoma of the retroperitoneal lymph
nodes 10 years after sigmoid colectomy. At that time,
he received chemotherapy for this retroperitoneal
nodal neoplasm. Eighteen months later, metastatic
sigmoid cancer involving the bladder was found with
the presentation of hematuria. It seems likely that the
occult metastatic colon cancer cells were able to
develop as a result of immunosuppression caused by
the chemotherapy. Recent studies have shown that
complicated biochemical and humoral interactions
between the microvasculature of tumors and other
cells within the neoplastic microenvironment may
play an important role in the dissemination of CRC
cells [13,14]. However, our case was originally classi-
fied as UICC stage II without nodal involvement, but
he still experienced recurrent metastasis 13 years
after curative resection. Progressive age-related
occult cancer cell reactivation is the only proposed
explanation for this recurrence.
Kaiser et al reported that the mean time between
the primary and the recurrent tumor was 25 months
(range, 1–252 months) with 82% of the recurrences
within 3 years after surgery [8]. The recurrence interval
was inversely correlated with the initial tumor stage.
Poor survival was associated with a short recurrence
interval (< 12 months) and a distant recurrence site.
The exact mechanism of postoperative colon cancer
recurrence after 13 years in our case remains largely
unknown. In fact, stage II tumors (negative nodal sta-
tus), as in our case at initial resection, have a signifi-
cantly longer recurrence time than stage III tumors.
Moreover, there may be some occult metastatic cancer
cells that are suppressed by humoral immune cells that
are activated when the host’s immune function is sup-
pressed for some reason. However, this hypothesis
needs to be evaluated in further studies.
The symptoms of hematuria and bloody stool in
our patient are probably due to irritation or erosion
of the bladder and bowel tract by the metastatic can-
cer cells based on the intraoperative and pathologic
observations. The pathologic findings showed the
presence of metastatic cancer cells in the serosa, mus-
cularis propria and submucosal layer, but not the
mucosal layer. The mucosal layer only showed ero-
sive changes, but no signs of neoplastic invasion.
These findings support the clinical presentation of
our patient.
In conclusion, we have described this rare case to
remind clinicians that a postoperative relapse can
occur as late as 13 years after primary tumor resec-
tion, despite its low incidence rate. A comprehensive
evaluation of the clinical symptoms and signs in pa-
tients after curative resection for CRC might reveal a
recurring tumor at a resectable stage and improve the
outcome for that recurrence. Further studies are nee-
ded to determine whether a more intensive follow-up
or increasing the duration of the follow-up period
would affect the outcomes for such patients.
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大腸癌手術後十三年復發以血尿為臨床表徵：
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大腸癌手術後十三年發生復發是非常罕見的病例，通常大腸癌手術後會在三年內復
發，而於手術五年後再復發的機率只有 5–7%，手術後超過十年再發的機率更是少
數。在此我們報告一名 72 歲男性大腸癌病患，在切除手術十三年後復發，因血尿到
診所就診，後有血便情形。理學檢查時發現下腹部正中央處有一個壓痛的硬塊，經由
電腦斷層檢查發現一腫瘤附著於遠端空腸壁與膀胱壁外，血清胚胎抗原指數高達 32 
ng/dL。經由手術切除病灶後病理組織報告證實為再發性大腸癌侵犯空腸與前腹壁。
關鍵詞：大腸癌，血尿，復發間隔時間
（高雄醫誌 2010;26:211–6）
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